| pemetrexed vs pemetrexed/erlotinib in EGFR acquired resistance - 1290362 |
|
jjkk |
Full Archive |
| Switching from Iressa to Tarceva - 1290356 |
|
samdig1 |
Full Archive |
| Pericardial Effusion, Afatinib - 1290352 |
|
deniseabrock |
Full Archive |
| KEYTRUDA AS FIRST LINE TREATMENT OF STAGE IIIA NSCLC W/ HIGH PD-L1 EXP. - 1290324 |
|
nazimi |
Full Archive |
| Lymphedema Massage - 1290319 |
|
marieharvey |
Full Archive |
| Tyrosine As An Ingredient In Protein Powder - Dangerous to TKI Therapy? - 1290318 |
|
lessie |
Full Archive |
| mBAC / AIS and immunotherapy nivolumab - 1290307 |
|
dutch46 |
Full Archive |
| Interim Alimta due to concurrent PPI and TKI use - 1290278 |
|
samdig1 |
Full Archive |
| Breast cancer metastases? - 1290275 |
|
follansbee |
Full Archive |
| Brigatinib (AP26113) and hair loss - 1290270 |
|
sd2011 |
Full Archive |